Screener
Teladoc Health TDOC Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Teladoc Health’s reported figures.
Based on trailing twelve months.
The source filing: Teladoc Health’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:54 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001477449-26-000038
FAQ
- What is Teladoc Health's return on equity?
- Teladoc Health (TDOC) reported return on equity of -13% in Q2 2026.
- How has Teladoc Health's return on equity changed year-over-year?
- Teladoc Health's return on equity increased by 8.4% year-over-year, from -14.2% to -13%.
- What is the long-term trend for Teladoc Health's return on equity?
- Over 5 years (2020 to 2025), Teladoc Health's return on equity has grown at a 19.4% compound annual growth rate (CAGR), from -5.7% to -13.9%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Teladoc Health's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude